PLIVA Hrvatska d.o.o. (Pliva Croatia Ltd.)
PolandAll drugs from this manufacturer
-
The medicinal product is used in postmenopausal women to treat a certain type of advanced or metastatic breast cancer with the presence of estrogen receptors. It may also be used in combination with another medicinal product (palbociclib) in women with hormone receptor-positive breast cancer.
Dosage form: solution for injection in ampoule-syringe
Active substance Dosage fulvestrant 250 mg/ 5 ml ATC: L02BA03
-
The medicine is used to accelerate the recovery of muscle function after surgery, allowing the patient to breathe independently sooner. It works by binding specific muscle relaxants (rocuronium bromide or vecuronium bromide) administered during anesthesia within the body.
Dosage form: solution for injection
Active substance Dosage sodium sugammadex 108.8 mg/ml ATC: V03AB35